Pfizer announces new CFO
Alcatel-Lucent exec Frank D'Amelio will join Pfizer as senior VP and chief financial officer in mid-September. Currently Senior Executive VP, Integration and Chief Administrative Officer at Alcatel-Lucent, D'Amelio has also held senior management positions at AT&T and Lucent Technologies. In his new role D'Amelio will be responsible for all aspects of the Pfizer's finances, including treasury, tax, the controller's division and investor development. D'Amelio succeeds Alan Levin, whose resignation from the company was announced in May. D'Amelio will report to Pfizer Chairman and CEO Jeff Kindler...
You may also be interested in...
Exec Chat: How Edwards Lifesciences Deploys AI, Remote Monitoring To Help Doctors Make Life-Critical Decisions
Edwards Lifesciences’ head of critical care expects that “smart recovery” AI-driven products will grow the fastest in its critical care unit, which is expected to reach $800m in total revenues for 2021.
I.V. Korsuva now has an August FDA action date, which partner Vifor would commercialize in the ESRD dialysis setting while Cara works toward a broad anti-pruritus label for its oral tablet formulation.
China, Iran and especially Russia have launched campaigns aimed at undermining confidence in Western vaccines, especially Pfizer’s, according to two reports.